The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. (Q37981103)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 February 2012

Language	Label	Description	Also known as
English	The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.	scientific article published on 02 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

0 references

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

David L Paterson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

S J van Hal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

T P Lodise

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

2 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

54

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

755-771

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22302374%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus disease in three communities

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an Emergency Department of a medical centre in Taiwan.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin minimum inhibitory concentration as a predictor of mortality in methicillin-resistant Staphylococcus aureus bacteremia: a second look

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin: we can't get there from here.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR935

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37981103&oldid=2106469452"